Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Current Leases (2019 - 2025)

Apyx Medical (APYX) has disclosed Current Leases for 7 consecutive years, with $407000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Leases rose 21.49% year-over-year to $407000.0, compared with a TTM value of $407000.0 through Dec 2025, up 21.49%, and an annual FY2025 reading of $407000.0, up 21.49% over the prior year.
  • Current Leases was $407000.0 for Q4 2025 at Apyx Medical, up from $393000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $407000.0 in Q4 2025 and bottomed at $20000.0 in Q1 2024.
  • Average Current Leases over 5 years is $202800.0, with a median of $221500.0 recorded in 2021.
  • Peak annual rise in Current Leases hit 1670.0% in 2025, while the deepest fall reached 93.61% in 2025.
  • Year by year, Current Leases stood at $122000.0 in 2021, then tumbled by 69.67% to $37000.0 in 2022, then skyrocketed by 837.84% to $347000.0 in 2023, then decreased by 3.46% to $335000.0 in 2024, then rose by 21.49% to $407000.0 in 2025.
  • Business Quant data shows Current Leases for APYX at $407000.0 in Q4 2025, $393000.0 in Q3 2025, and $20000.0 in Q2 2025.